At some point in collaborations formal arrangements – in whatever form – will become relevant. Please involve IXA at the earliest stage possible to assist you with this. The IXA legal counsels have extensive experience in drafting and negotiating contracts. Do you have a request from industry regarding the use of your research results? At IXA we are committed to negotiating a fair deal.
In many cases, the COVID-19 crisis has an impact on current research contracts with cooperation partners and grant providers. For more information about force majeure due to COVID-19 please look at this page.
Please do not hesitate to contact our legal department if you need advice in matters such as:
Azafaros B.V. announced today that the first cohort of healthy subjects has been dosed in a two-part Phase 1 clinical study with clinical candidate AZ-3102, a first-in-class small molecule compound being developed for the treatment of rare neurogenetic disorders. This double-blind, placebo-controlled, Phase 1 study is evaluating the safety and tolerability of ascending single- (SAD) […]
NewsOptics11 and Optics11 Life have secured funding from Rabobank. The funding will be used to strongly accelerate growth across global markets, to further build the team for the future and to strategically expand the high-tech product portfolios of both business units. “This is the right moment to pick up the pace. Rabobank’s funding helps us […]
NewsIs it possible to create a cup of coffee that’s healthy and tasty? At the entrepreneurship laboratory Demonstrator Lab at the Vrije Universiteit, Florian Fermin (27) and Stefan Wateler (26) developed Cuppelement, a Fairtrade biodegradable coffee capsule with added superfoods and vitamins. During the Dutch TV program Dragons Den, the entrepreneurs successfully persuaded the dragons […]
News